Skip Nav Destination
Issues
1 August 2021
-
Cover Image
Cover Image
Pseudofluorescent image of the tumor microenvironment of a muscle-invasive bladder cancer specimen using multiplex immunohistochemistry on a single slide. The image depicts CD3 staining in red, CD8 staining in yellow, CD68 staining in green, PD-L1 staining in magenta, pancytokeratin staining in blue, and nuclei stained in gray. For details, see the article by Wang and colleagues on page 4287 of this issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
CCR Drug Updates
FDA Approval Summary: Selumetinib for Plexiform Neurofibroma
Denise Casey; Suzanne Demko; Arup Sinha; Pallavi S. Mishra-Kalyani; Yuan-li Shen; Sachia Khasar; M. Anwar Goheer; Whitney S. Helms; Lili Pan; Yuan Xu; Jianghong Fan; Ruby Leong; Jiang Liu; Yuching Yang; Katherine Windsor; Mei Ou; Olen Stephens; Byeongtaek Oh; Gregory H. Reaman; Abhilasha Nair; Stacy S. Shord; Vishal Bhatnagar; Selena R. Daniels; Sharon Sickafuse; Kirsten B. Goldberg; Marc R. Theoret; Richard Pazdur; Harpreet Singh
Review
Clinical Trials: Targeted Therapy
Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial
Vivek Subbiah; Justin F. Gainor; Geoffrey R. Oxnard; Daniel S.W. Tan; Dwight H. Owen; Byoung Chul Cho; Herbert H. Loong; Caroline E. McCoach; Jared Weiss; Yu Jung Kim; Lyudmila Bazhenova; Keunchil Park; Haruko Daga; Benjamin Besse; Oliver Gautschi; Christian Rolfo; Edward Y. Zhu; Jennifer F. Kherani; Xin Huang; Suhyun Kang; Alexander Drilon
First-Line Afatinib plus Cetuximab for EGFR-Mutant Non–Small Cell Lung Cancer: Results from the Randomized Phase II IFCT-1503 ACE-Lung Study
Alexis B. Cortot; Anne Madroszyk; Etienne Giroux-Leprieur; Olivier Molinier; Elisabeth Quoix; Henri Bérard; Josiane Otto; Isabelle Rault; Denis Moro-Sibilot; Judith Raimbourg; Elodie Amour; Franck Morin; José Hureaux; Lionel Moreau; Didier Debieuvre; Hugues Morel; Aldo Renault; Eric Pichon; Benjamin Huret; Sandrine Charpentier; Marc G. Denis; Jacques Cadranel
Author Choice
Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)
Aditya Bardia; Sara A. Hurvitz; Angela DeMichele; Amy S. Clark; Amelia Zelnak; Denise A. Yardley; Meghan Karuturi; Tara Sanft; Sibel Blau; Lowell Hart; Cynthia Ma; Hope S. Rugo; Das Purkayastha; Stacy Moulder
A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
Wei-Xiong Xia; Xing Lv; Hu Liang; Guo-Ying Liu; Rui Sun; Qi Zeng; Si-Wei Li; Hao-Yuan Mo; Fei Han; Dong-Hua Luo; Qing Liu; Meng-Yun Shi; Yan-Fang Ye; Jing Yang; Liang-Ru Ke; Meng-Yun Qiang; Wen-Ze Qiu; Ya-Hui Yu; Kui-Yuan Liu; Xin-Jun Huang; Wang-Zhong Li; Shu-Hui Lv; Zhuo-Chen Cai; Jing-Jing Miao; Ling Guo; Ming-Yuan Chen; Ka-Jia Cao; Lin Wang; Chong Zhao; Pei-Yu Huang; Qiu-Yan Chen; Yi-Jun Hua; Lin-Quan Tang; Chao-Nan Qian; Hai-Qiang Mai; Xiang Guo; Yan-Qun Xiang
Clinical Trials: Immunotherapy
Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma
Yana G. Najjar; Dustin McCurry; Huang Lin; Yan Lin; Yan Zang; Diwakar Davar; Arivarasan Karunamurthy; Joseph J. Drabick; Rogerio I. Neves; Lisa H. Butterfield; Marc S. Ernstoff; Igor Puzanov; Joseph J. Skitzki; Jennifer Bordeaux; IlaSri B. Summit; Jehovana O. Bender; Ju Young Kim; Beiru Chen; Ghanashyam Sarikonda; Anil Pahuja; Jennifer Tsau; Zeni Alfonso; Christian Laing; James F. Pingpank; Matthew P. Holtzman; Cindy Sander; Amy Rose; Hassane M. Zarour; John M. Kirkwood; Ahmad A. Tarhini
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial
Reetta Virtakoivu; Jenna H. Rannikko; Miro Viitala; Felix Vaura; Akira Takeda; Tapio Lönnberg; Jussi Koivunen; Panu Jaakkola; Annika Pasanen; Shishir Shetty; Maja J.A. de Jonge; Debbie Robbrecht; Yuk Ting Ma; Tanja Skyttä; Anna Minchom; Sirpa Jalkanen; Matti K. Karvonen; Jami Mandelin; Petri Bono; Maija Hollmén
Precision Medicine and Imaging
Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA
Xiaoji Chen; Zhao Dong; Earl Hubbell; Kathryn N. Kurtzman; Geoffrey R. Oxnard; Oliver Venn; Collin Melton; Christina A. Clarke; Rita Shaknovich; Ting Ma; Gerry Meixiong; Michael V. Seiden; Eric A. Klein; Eric T. Fung; Minetta C. Liu
Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
Justin M. Burgener; Jinfeng Zou; Zhen Zhao; Yangqiao Zheng; Shu Yi Shen; Shao Hui Huang; Sareh Keshavarzi; Wei Xu; Fei-Fei Liu; Geoffrey Liu; John N. Waldron; Ilan Weinreb; Anna Spreafico; Lillian L. Siu; John R. de Almeida; David P. Goldstein; Michael M. Hoffman; Daniel D. De Carvalho; Scott V. Bratman
Standardized Uptake Value for 18F-Fluorodeoxyglucose Is a Marker of Inflammatory State and Immune Infiltrate in Cervical Cancer
John M. Floberg; Jin Zhang; Naoshad Muhammad; Todd A. DeWees; Matthew Inkman; Kevin Chen; Alexander J. Lin; Ramachandran Rashmi; Kay Jayachandran; Brian T. Edelson; Barry A. Siegel; Farrokh Dehdashti; Perry W. Grigsby; Stephanie Markovina; Julie K. Schwarz
Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E-Driven Papillary Thyroid Cancer Patients
Theodora Pappa; Sara Ahmadi; Ellen Marqusee; Hannah L. Johnson; Matthew A. Nehs; Nancy L. Cho; Justine A. Barletta; Jochen H. Lorch; Gerard M. Doherty; Neal I. Lindeman; Erik K. Alexander; Iñigo Landa
Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms
Charles W. Abbott; Sean M. Boyle; Rachel Marty Pyke; Lee D. McDaniel; Eric Levy; Fábio C.P. Navarro; Dattatreya Mellacheruvu; Simo V. Zhang; Mengyao Tan; Rose Santiago; Zeid M. Rusan; Pamela Milani; Gabor Bartha; Jason Harris; Rena McClory; Michael P. Snyder; Sekwon Jang; Richard Chen
Translational Cancer Mechanisms and Therapy
Myeloid Cell–associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing
Li Wang; John P. Sfakianos; Kristin G. Beaumont; Guray Akturk; Amir Horowitz; Robert P. Sebra; Adam M. Farkas; Sacha Gnjatic; Austin Hake; Sudeh Izadmehr; Peter Wiklund; William K. Oh; Peter M. Szabo; Megan Wind-Rotolo; Keziban Unsal-Kacmaz; Xin Yao; Eric Schadt; Padmanee Sharma; Nina Bhardwaj; Jun Zhu; Matthew D. Galsky
Regulation of OATP1B1 Function by Tyrosine Kinase–mediated Phosphorylation
Elizabeth R. Hayden; Mingqing Chen; Kyle Z. Pasquariello; Alice A. Gibson; James J. Petti; Shichen Shen; Jun Qu; Su Sien Ong; Taosheng Chen; Yan Jin; Muhammad Erfan Uddin; Kevin M. Huang; Aviv Paz; Alex Sparreboom; Shuiying Hu; Jason A. Sprowl
Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion
Fabio Conforti; Laura Pala; Eleonora Pagan; Vincenzo Bagnardi; Tommaso De Pas; Paola Queirolo; Elisabetta Pennacchioli; Chiara Catania; Emilia Cocorocchio; Pier Francesco Ferrucci; Maristella Saponara; Gianmarco Orsolini; Paola Zagami; Eleonora Nicoló; Filippo De Marinis; Giampaolo Tortora; Emilio Bria; Saverio Minucci; Hadine Joffe; Paolo Veronesi; Jennifer Wargo; Rachel Rosenthal; Charles Swanton; Alberto Mantovani; Richard D. Gelber; Giuseppe Viale; Aron Goldhirsch; Giuseppe Giaccone
Opening of the Blood–Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models
Aria Sabbagh; Kevin Beccaria; Xiaoyang Ling; Anantha Marisetty; Martina Ott; Hillary Caruso; Emily Barton; Ling-Yuan Kong; Dexing Fang; Khatri Latha; Daniel Yang Zhang; Jun Wei; John DeGroot; Michael A. Curran; Ganesh Rao; Jian Hu; Carole Desseaux; Guillaume Bouchoux; Michael Canney; Alexandre Carpentier; Amy B. Heimberger
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
Lin Xiao; Klaartje Somers; Jayne Murray; Ruby Pandher; Mawar Karsa; Emma Ronca; Angelika Bongers; Rachael Terry; Anahid Ehteda; Laura D. Gamble; Natalia Issaeva; Katerina I. Leonova; Aisling O'Connor; Chelsea Mayoh; Pooja Venkat; Hazel Quek; Jennifer Brand; Frances K. Kusuma; Jessica A. Pettitt; Erin Mosmann; Adam Kearns; Georgina Eden; Stephanie Alfred; Sophie Allan; Lei Zhai; Alvin Kamili; Andrew J. Gifford; Daniel R. Carter; Michelle J. Henderson; Jamie I. Fletcher; Glenn Marshall; Ricky W. Johnstone; Anthony J. Cesare; David S. Ziegler; Andrei V. Gudkov; Katerina V. Gurova; Murray D. Norris; Michelle Haber
Inhibition of DNA-PK with AZD7648 Sensitizes Tumor Cells to Radiotherapy and Induces Type I IFN-Dependent Durable Tumor Control
Kyoko Nakamura; Ankur Karmokar; Paul M. Farrington; Neil H. James; Antonio Ramos-Montoya; Susan J. Bickerton; Gareth D. Hughes; Timothy M. Illidge; Elaine B. Cadogan; Barry R. Davies; Simon J. Dovedi; Viia Valge-Archer
Darolutamide Potentiates the Antitumor Efficacy of a PSMA-targeted Thorium-227 Conjugate by a Dual Mode of Action in Prostate Cancer Models
Stefanie Hammer; Andreas Schlicker; Sabine Zitzmann-Kolbe; Simon Baumgart; Urs B. Hagemann; Arne Scholz; Bernard Haendler; Pascale Lejeune; Jenny Karlsson; Christine Ellingsen; Hartwig Hennekes; Carsten H. Nielsen; Mark U. Juul; Dominik Mumberg; Christoph A. Schatz
Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER+ Breast Cancer
Alberto Servetto; Rahul Kollipara; Luigi Formisano; Chang-Ching Lin; Kyung-Min Lee; Dhivya R. Sudhan; Paula I. Gonzalez-Ericsson; Sumanta Chatterjee; Angel Guerrero-Zotano; Saurabh Mendiratta; Hiroaki Akamatsu; Nicholas James; Roberto Bianco; Ariella B. Hanker; Ralf Kittler; Carlos L. Arteaga
Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma
Seok-Young Kim; Sang-Min Kim; Sumin Lim; Ji Yeon Lee; Su-Jin Choi; San-Duk Yang; Mi Ran Yun; Chang Gon Kim; Seo Rin Gu; Chaewon Park; A-Young Park; Sun Min Lim; Seong Gu Heo; HyunKi Kim; Byoung Chul Cho
HYAL4-V1/Chondroitinase (Chase) Drives Gemcitabine Resistance and Predicts Chemotherapy Failure in Patients with Bladder Cancer
Sarrah L. Hasanali; Daley S. Morera; Ronny R. Racine; Martin Hennig; Santu Ghosh; Luis E. Lopez; Marie C. Hupe; Diogo O. Escudero; Jiaojiao Wang; Huabin Zhu; Semih Sarcan; Ijeoma Azih; Michael Zhou; Andre R. Jordan; Martha K. Terris; Markus A. Kuczyk; Axel S. Merseburger; Vinata B. Lokeshwar
Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain Metastasis
Alex Man Lai Wu; Selamawit Gossa; Ramakrishna Samala; Monika A. Chung; Brunilde Gril; Howard H. Yang; Helen R. Thorsheim; Andy D. Tran; Debbie Wei; Esra Taner; Kristine Isanogle; Yuan Yang; Emma L. Dolan; Christina Robinson; Simone Difilippantonio; Maxwell P. Lee; Imran Khan; Quentin R. Smith; Dorian B. McGavern; Lalage M. Wakefield; Patricia S. Steeg
Neutralization of PD-L2 is Essential for Overcoming Immune Checkpoint Blockade Resistance in Ovarian Cancer
Yu Rebecca Miao; Kaushik N. Thakkar; Jin Qian; Mihalis S. Kariolis; Wei Huang; Saravanan Nandagopal; Teddy Tat Chi Yang; Anh N. Diep; Gerald Maxwell Cherf; Yu Xu; Eui Jung Moon; Yiren Xiao; Haizea Alemany; Tiane Li; Wenhua Yu; Bo Wei; Erinn B. Rankin; Amato J. Giaccia
Editor’s Notes
Editor's Note: Biologic Effects of Platelet-Derived Growth Factor Receptor α Blockade in Uterine Cancer
Ju-Won Roh; Jie Huang; Wei Hu; XiaoYun Yang; Nicholas B. Jennings; Vasudha Sehgal; Bo Hwa Sohn; Hee Dong Han; Sun Joo Lee; Duangmani Thanapprapasr; Justin Bottsford-Miller; Behrouz Zand; Heather J. Dalton; Rebecca A. Previs; Ashley N. Davis; Koji Matsuo; Ju-Seog Lee; Prahlad Ram; Robert L. Coleman; Anil K. Sood
Editor's Note: Targeting Src in Mucinous Ovarian Carcinoma
Koji Matsuo; Masato Nishimura; Justin N. Bottsford-Miller; Jie Huang; Kakajan Komurov; Guillermo N. Armaiz-Pena; Mian M.K. Shahzad; Rebecca L. Stone; Ju Won Roh; Angela M. Sanguino; Chunhua Lu; Dwight D. Im; Neil B. Rosenshien; Atsuko Sakakibara; Tadayoshi Nagano; Masato Yamasaki; Takayuki Enomoto; Tadashi Kimura; Prahlad T. Ram; Kathleen M. Schmeler; Gary E. Gallick; Kwong K. Wong; Michael Frumovitz; Anil K. Sood
Editor's Note: Dopamine Blocks Stress-mediated Ovarian Carcinoma Growth
Myrthala Moreno-Smith; Chunhua Lu; Mian M.K. Shahzad; Guillermo N. Armaiz Pena; Julie K. Allen; Rebecca L. Stone; Lingegowda S. Mangala; Hee Dong Han; Hye Sun Kim; Donna Farley; Gabriel Lopez Berestein; Steve W. Cole; Susan K. Lutgendorf; Anil K. Sood
Editor's Note: Functional Roles of Src and Fgr in Ovarian Carcinoma
Hye-Sun Kim; Hee Dong Han; Guillermo N. Armaiz-Pena; Rebecca L. Stone; Eun Ji Nam; Jeong-Won Lee; Mian M.K. Shahzad; Alpa M. Nick; Sun Joo Lee; Ju-Won Roh; Masato Nishimura; Lingegowda S. Mangala; Justin Bottsford-Miller; Gary E. Gallick; Gabriel Lopez-Berestein; Anil K. Sood
Editor's Note: Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
Hee Dong Han; Lingegowda S. Mangala; Jeong Won Lee; Mian M.K. Shahzad; Hye Sun Kim; Deyu Shen; Eun Ji Nam; Edna M. Mora; Rebecca L. Stone; Chunhua Lu; Sun Joo Lee; Ju Won Roh; Alpa M. Nick; Gabriel Lopez-Berestein; Anil K. Sood
Editor's Note: Therapeutic Targeting of ATP7B in Ovarian Carcinoma
Lingegowda S. Mangala; Vesna Zuzel; Rosemarie Schmandt; Erik S. Leshane; Jyotsna B. Halder; Guillermo N. Armaiz-Pena; Whitney A. Spannuth; Takemi Tanaka; Mian M.K. Shahzad; Yvonne G. Lin; Alpa M. Nick; Christopher G. Danes; Jeong-Won Lee; Nicholas B. Jennings; Pablo E. Vivas-Mejia; Judith K. Wolf; Robert L. Coleman; Zahid H. Siddik; Gabriel Lopez-Berestein; Svetlana Lutsenko; Anil K. Sood
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds